Discovery and preliminary SARs of keto-indoles as novel indoleamine 2,3-dioxygenase (IDO) inhibitors

E. Dolušić, P. Larrieu, S. Blanc, F. Sapunaric, J. Pouyez, L. Moineaux, D. Colette, V. Stroobant, L. Pilotte, D. Colau, Thierry Ferain, G. Fraser, M. Galleni, Jean-Marie Frère, B. Masereel, B. Van Den Eynde, J. Wouters, R. Frédérick

Résultats de recherche: Contribution à un journal/une revueArticle

Résumé

Indoleamine 2,3-dioxygenase (IDO) is an important new therapeutic target for the treatment of cancer. With the aim of discovering novel IDO inhibitors, a virtual screen was undertaken and led to the discovery of the keto-indole derivative 1a endowed with an inhibitory potency in the micromolar range. Detailed kinetics were performed and revealed an uncompetitive inhibition profile. Preliminary SARs were drawn in this series and corroborated the putative binding orientation as suggested by docking. © 2011 Elsevier Masson SAS. All rights reserved.
langue originaleAnglais
Pages (de - à)3058-3065
Nombre de pages8
journalEuropean Journal of Medicinal Chemistry
Volume46
Numéro de publication7
Les DOIs
Etat de la publicationPublié - 2011

    Empreinte digitale

Contient cette citation

Dolušić, E., Larrieu, P., Blanc, S., Sapunaric, F., Pouyez, J., Moineaux, L., Colette, D., Stroobant, V., Pilotte, L., Colau, D., Ferain, T., Fraser, G., Galleni, M., Frère, J-M., Masereel, B., Van Den Eynde, B., Wouters, J., & Frédérick, R. (2011). Discovery and preliminary SARs of keto-indoles as novel indoleamine 2,3-dioxygenase (IDO) inhibitors. European Journal of Medicinal Chemistry, 46(7), 3058-3065. https://doi.org/10.1016/j.ejmech.2011.02.049